These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3953009)
1. [DNAse II from phagocytes in the study of the pathogenesis of systemic lupus erythematosus]. Matul'skaia LI; Klimov VIu; Riazantseva TA; Pleskovskaia GN Vopr Med Khim; 1986; 32(1):32-4. PubMed ID: 3953009 [TBL] [Abstract][Full Text] [Related]
2. The uptake and degradation of DNA is impaired in macrophages and dendritic cells from NZB/W F(1) mice. Ogawa Y; Yoshinaga T; Yasuda K; Nishikawa M; Takakura Y Immunol Lett; 2005 Oct; 101(1):32-40. PubMed ID: 15979158 [TBL] [Abstract][Full Text] [Related]
3. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice. Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346 [TBL] [Abstract][Full Text] [Related]
4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
6. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus. Fournel S; Muller S Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425 [TBL] [Abstract][Full Text] [Related]
8. [Systemic lupus erythematosus: disease or syndrome?]. Font J; Cardellach F Med Clin (Barc); 1985 Apr; 84(16):657-9. PubMed ID: 3875769 [No Abstract] [Full Text] [Related]
9. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice. Alleva DG; Kaser SB; Beller DI J Immunol; 1997 Dec; 159(11):5610-9. PubMed ID: 9548504 [TBL] [Abstract][Full Text] [Related]
10. Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice. Hsu TC; Huang CY; Chiang SY; Lai WX; Tsai CH; Tzang BS Eur J Pharmacol; 2008 Jan; 579(1-3):382-9. PubMed ID: 18031733 [TBL] [Abstract][Full Text] [Related]
11. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice. Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
13. [Experimental approach to the pathogenesis of systemic lupus erythematosus]. Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279 [No Abstract] [Full Text] [Related]